medigraphic.com

2006, Number S2

<< Back Next >>

Arch Cardiol Mex 2006; 76 (S2)

Risk of blood transfusion in cardiac surgery

Serrano VX

Language: Spanish
References: 15
Page: 86-91
PDF size: 97.04 Kb.


ABSTRACT

Bleeding occur frequently in patients undergoing cardiac surgery. Although unexpected bleeding after this surgery is common, reducing this bleeding is a desirable clinical goal, because such bleeding is associated with adverse outcomes. Bleeding during and after cardiac operations and the hemodilution effects of cardiopulmonary bypass commonly result in blood transfusions. Despite institutional efforts to curtail the frequency of blood transfusions in cardiac operation, the frequency remains high. If transfusions were completely safe, differing thresholds would not matter. However, the adverse reactions associated with transfusions are: febrile reactions, hemolytic and infectious complications may occur. Most recently, blood transfusions have been linked to postoperative wound infections, pneumonia, renal dysfunction, severe sepsis, hospital mortality and increased 5-year mortality.


REFERENCES

  1. ENGOREN MC, AVIV RH, ET AL: Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-6.

  2. GOODNOUGH JOHNSTON MF, ET AL: The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86-90.

  3. SAZAMA K: Reports of 355 transfusion-associated deaths. 1976-1985. Transfusion 1990; 30: 583-90. 4. GOLDMAN M, BLAJCHMAN MA: Blood product associated bacterial sepsis. Transfusion. Med Rev 1991; 5: 73-83.

  4. GOODNOUGH LT: Risk of blood transfusion. Anesthesiology. Clin N Am 2005; 23: 241-252.

  5. SILLIMAN CC, BOSHKOV LK: Transfusion-related acute lung injury: epidemiology and prospective analysis of etiologic factors.

  6. WALLIS JP: Transfusion-related acute lung injury (TRALI)-under-diagnosed and under-reported. British Jour of Anaest 2003; 90(5): 573-5.

  7. BERDÍN JO, HEDDLE NM, BLOJCHMAN MA: Biologic effects of leucocytes present in transfused cellular blood products. Blood 1994; 84: 1703-21.

  8. MYNSTER T, CHRISTENSEN IJ, ET AL: Effects of the combination ob blood tranfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Britsh Jour of Surg 2000; 87: 1553-62.

  9. VAN DE WATERING LMG, HERMANS J, ET AL: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97: 562-8.

  10. MEZROW CK, BERGSTEIN I, TARTTER PI: Postoperative infections after autologous and homologous blood transfusion. Transfusion 1992; 32: 27-30.

  11. LEAL-NOVAL, SANTIAGO RAMÓN MD, FERRARI R, ET AL: Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest2001;119(5): 1461-68.

  12. SHORE-LESSERSON L: Myocardial injury in Cardiac Surgery: The role of transfusion. Journal of Card and Vasc Anest 2000; 14 (3)suppl 1: 11-14.

  13. PEARL JM, DRINKWATER DC, ET AL: Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J SurgRes1992;52: 298-308.

  14. LEAL-NOVAL SR, JARA-LOPEZ I, ET AL: Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003; 98(4): 8l5-22.

  15. SHANDER A, ET AL: Clinical outcomes in Cardiac Surgery: Conventional surgery vs bloodless surgery. Anesthesiology Clin N Am 2005; (23): 327-345.




2020     |     www.medigraphic.com